Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: Behavioural Development, Long-term Outcomes and Opportunities to Optimize Youth Mental Health Trajectories
This clinical trial update describes a study led by Douglas Mental Health University Institute examining behavioural development, long-term …
-
CLINICAL_TRIALS trial_result · 2025-05-18Clinical Trial Update: DIALOG: Understanding Disorganisation: A Language-focused Global Initiative in Psychosis
This entry describes the DIALOG study, a language-focused global initiative in psychosis led by Douglas Mental Health University Institute. …
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: Xenon Inhalation Therapy for Major Depressive Disorder and Bipolar Disorder [EARLY_Phase 1]
A Phase 1 clinical trial is recruiting to evaluate xenon inhalation therapy for major depressive disorder and bipolar disorder.
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: A Pilot Study Investigating the Efficacy of Minocycline and N-Acetyl Cysteine for Bipolar Depression [Phase 4]
A Phase 4 pilot study evaluating the efficacy of minocycline and N-acetylcysteine for bipolar depression has been suspended.
-
FDA approval · 2025-05-16FDA Approved: RISPERIDONE — Supplemental Application (Westminster Pharmaceuticals, LLC)
FDA approved Westminster Pharmaceuticals, LLC's supplemental application for risperidone under an ANDA.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Ketogenic Metabolic Therapy in Schizophrenia, Bipolar Disorder, Major Depressive Disorder: Deep Omic Profiling [NA]
A Stanford University-sponsored trial investigates ketogenic metabolic therapy (ketogenic dieting) for schizophrenia, bipolar disorder, and …
-
FDA approval · 2025-05-16FDA Approved: OLANZAPINE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s original generic application for olanzapine, establishing a generic version of the antipsychot…
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Mood Stabilizer (MS)+ Antidepressant vs MS + Placebo in Maintenance of Bipolar Disorder. [Phase 3]
A Phase 3 maintenance trial comparing mood stabilizer plus antidepressant versus mood stabilizer plus placebo in Bipolar I Disorder was term…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Skills for Wellness [NA]
This is a clinical trial update for the Skills for Wellness study. It is currently recruiting participants with schizophrenia, bipolar disor…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: The Canadian Depression Research and Intervention Network (CDRIN) Maritimes Registry
Clinical trial update announcing the CDRIN Maritimes Registry, a prospective registry for depression and trauma-related disorders, currently…
-
CLINICAL_TRIALS trial_result · 2025-05-14Clinical Trial Update: IM Ketamine vs Midazolam for Suicidal ER Patients [Phase 4]
A Phase 4 randomized trial comparing intramuscular ketamine to midazolam for emergency department patients with depression and suicidal idea…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Genetic Counselling in the Prevention of Mental Health Consequences of Cannabis Use [NA]
A clinical trial evaluating whether genetic counselling can prevent mental health problems associated with cannabis use; the study is curren…
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Analysis of Early Neurodevelopmental Alterations in Bipolar Disorder Based on Cortical Organoid Models [NA]
An update on a clinical trial evaluating early neurodevelopmental alterations in bipolar disorder using cortical organoid models. The study …
-
EMA approval · 2025-05-12EMA Authorised: Olanzapine Teva (olanzapine) — Teva B.V.
The EMA authorised Teva B.V. to market Olanzapine for schizophrenia and bipolar disorder in the European Union.
-
CLINICAL_TRIALS research · 2025-05-09Clinical Trial Update: AMIloride for the Treatment of Nephrogenic Diabetes Insipidus for Patients With Bipolar Disorder Treated With Lithium [Phase 4]
Phase 4 clinical trial evaluating amiloride for nephrogenic diabetes insipidus in patients with bipolar disorder treated with lithium; trial…
-
CLINICAL_TRIALS withdrawal · 2025-05-04Clinical Trial Update: Sleep Quality, Cognitive Performance, and Computerized Cognitive Training
A clinical trial examining sleep quality, cognitive performance, and computerized cognitive training for bipolar disorder and major depressi…
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: Dallas 2K: A Natural History Study of Depression
Dallas 2K is a natural history study of depression sponsored by the University of Texas Southwestern Medical Center, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-04-30Clinical Trial Update: CBT for Problematic Impulsive Behaviours in Bipolar Disorder: A Case Series / CBT-PIB [NA]
A clinical trial evaluating cognitive behavioral therapy for problematic impulsive behaviours in bipolar disorder has been suspended.
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: Scopolamine in Bipolar Depression [Phase 2]
A Phase 2 clinical trial evaluating scopolamine for bipolar depression has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: Bipolar Disorder Measures in Clinical Care [NA]
A University of Cincinnati clinical trial evaluating measures used in routine clinical care for bipolar disorder has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: A Study of the Relationship of Psychosocial Function With Mood Symptoms in Offspring of Parents With Bipolar Disorder
This completed study explored how psychosocial functioning relates to mood symptoms in offspring of parents with bipolar disorder.
-
FDA approval · 2025-04-25FDA Approved: LAMICTAL XR — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Lamictal XR (lamotrigine) submitted by GlaxoSmithKline LLC. This action authorizes changes r…
-
FDA approval · 2025-04-25FDA Approved: LAMICTAL ODT — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for LAMICTAL ODT (lamotrigine) from GlaxoSmithKline LLC.
-
CLINICAL_TRIALS research · 2025-04-23Clinical Trial Update: Cannabidiol for Bipolar Depression (CBD-BD) [Phase 3]
A Phase 3 clinical trial investigating cannabidiol (CBD) for bipolar depression is currently recruiting.
-
FDA approval · 2025-04-21FDA Approved: LITHIUM CARBONATE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for Lithium Carbonate from Heritage Pharmaceuticals (d/b/a Avet Pharmaceuticals), indicating an appr…